SEC Form 4 · accession 0001683168-26-005419
Sonoma Pharmaceuticals, Inc. · SNOA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jerome J Dvonch
Officer — Chief Financial Officer
Period of report
Jul 9, 2026
Accepted (ET)
Jul 9, 2026 · 8:46 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001367083
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F3,F2 | $0.00 | Jul 9, 2026 | A | 10,000 | A | — | — | Common Stock | 10,000 | 44,391 | D |
Explanation of responses
- F1Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock.
- F2The RSUs on the third anniversary of the grant date, or upon change of control.
- F3The RSUs were awarded and granted to Mr. Dvonch for services performed.